德语国家法医医院和监狱中的普雷加巴林使用 - - 一项针对医生的调查研究
Michal Novotny1,2, Jan Bulla3, Daniela Hubl4
1Private Clinic Meiringen, Willigen, Switzerland.
Frontiers in public health
|January 23, 2024
概括
在瑞士的法医和监狱环境中,滥用普雷加巴林是一个重大问题,医生报告使用量增加,高剂量和戒断症状. 适当的医生教育关于普雷加巴林风险至关重要.
科学领域:
- 法医医学 法医医学
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 普雷加巴林是一种胺黄油酸 (GABA) 模拟剂,已被批准用于神经病痛,焦虑和.
- 自从它推出以来,观察到pregabalin滥用和滥用的显著增加.
- 关于瑞士法医医院和监狱内使用普雷加巴林的数据有限.
研究的目的:
- 调查德语国家法医和监狱环境中患者使用普加巴林的模式.
- 评估pregabalin滥用和相关挑战的流行情况.
- 收集医生关于普雷加巴林处方和患者行为的见解.
主要方法:
- 在德语国家,向监狱医生和法医分发了一份问卷调查.
- 收集和分析了131个回复.
主要成果:
- 超过80%的医生观察到pregabalin使用量增加,患者要求没有明确的迹象.
- 近90%的患者报告使用普雷加巴林与其他非法物质.
- 超过70%的患者超过了建议的每日剂量,有些人达到4200毫克/天.
- 85%观察到戒断症状,包括不满和攻击性.
- 医生主要将普雷加巴林开给外国患者,特别是来自西北非洲的患者.
结论:
- 在德语地区的法医和监狱医学中,普雷加巴林的使用构成了重大问题.
- 在这些情况下处方普雷加巴林可能会加剧现有的使用障碍问题和日常生活挑战.
- 提高医生对普雷加巴林风险和管理的认识至关重要.
相关概念视频
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
403
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
403
01:20Antiepileptic Drugs: Potassium Channel Activators
183
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
183
01:14CNS Depressants: Barbiturates and Benzodiazepines
267
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
267
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
176
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
176
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
303
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
303
01:26Psychosis: Goals of Pharmacotherapy
131
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
131